ATL 105
Alternative Names: alpha-1 antitrypsin - AATec Medical; ATL-105Latest Information Update: 04 Apr 2024
At a glance
- Originator AATec Medical
- Class Acute-phase proteins; Alpha globulins; Anti-inflammatories; Antiallergics; Antihyperglycaemics; Blood proteins; Secretory proteinase inhibitory proteins; Serpins
- Mechanism of Action Alpha 1-antitrypsin replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Adult respiratory distress syndrome; Allergic asthma; Bronchiectasis; Bronchiolitis obliterans; Chronic obstructive pulmonary disease; Respiratory tract infections
Most Recent Events
- 02 Apr 2024 Preclinical trials in Allergic asthma in Germany (Inhalation) before April 2024 (AATec Medical pipeline, April 2024)
- 02 Apr 2024 Preclinical trials in Bronchiectasis in Germany (Inhalation) before April 2024 (AATec Medical pipeline, April 2024)
- 02 Apr 2024 Preclinical trials in Bronchiolitis Obliterans in Germany (Inhalation) before April 2024 (AATec Medical pipeline, April 2024)